Literature DB >> 12150644

Mismatch negativity in chronic schizophrenia and first-episode schizophrenia.

Dean F Salisbury1, Martha E Shenton, Carlye B Griggs, Aaron Bonner-Jackson, Robert W McCarley.   

Abstract

BACKGROUND: Mismatch negativity (MMN) is an event-related brain potential that is sensitive to stimulus deviation from a repetitive pattern. The MMN is thought primarily to reflect the activity of sensory memory, with, at most, moderate influences of higher-level cognitive processes, such as attention. The MMN is reported to be reduced in patients with chronic schizophrenia. However, it is unknown whether MMN is reduced in patients with first-episode schizophrenia (at first hospitalization).
METHODS: Subject groups comprised patients with chronic schizophrenia (n = 16) and older control subjects (n = 13), and patients with first-episode schizophrenia (n = 21) and younger control subjects (n = 27). The MMN was visualized by subtracting the averaged event-related brain potential to standard tones (1 kHz [95% of all tones]) from the event-related brain potential to pitch-deviant tones (1.2 kHz [5% of all tones]). The MMN voltage was the mean voltage from 100 to 200 milliseconds.
RESULTS: Pitch-deviant MMN was reduced by approximately 47% in patients with chronic illness along the sagittal midline relative to controls. The MMN was not reduced in patients with first-episode schizophrenia. All 4 groups showed approximately 64% larger MMN to pitch-deviant tones over the right hemisphere compared with the left hemisphere.
CONCLUSIONS: The pitch-deviant MMN reductions present in patients with chronic schizophrenia are not present at first hospitalization. The sensory, echoic memory functions indexed by MMN seem unaffected early in the schizophrenia disease process. Reductions in MMN amplitude may develop over time and index the progression of the disorder, although that can only be definitively determined by longitudinal assessments.

Entities:  

Mesh:

Year:  2002        PMID: 12150644     DOI: 10.1001/archpsyc.59.8.686

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  94 in total

1.  Failure to find P50 suppression deficits in young first-episode patients with schizophrenia and clinically unaffected siblings.

Authors:  O M de Wilde; L J Bour; P M Dingemans; J H T M Koelman; D H Linszen
Journal:  Schizophr Bull       Date:  2007-02-07       Impact factor: 9.306

Review 2.  Combining ERP and structural MRI information in first episode schizophrenia and bipolar disorder.

Authors:  Robert W McCarley; Motoaki Nakamura; Martha E Shenton; Dean F Salisbury
Journal:  Clin EEG Neurosci       Date:  2008-04       Impact factor: 1.843

3.  Are auditory-evoked frequency and duration mismatch negativity deficits endophenotypic for schizophrenia? High-density electrical mapping in clinically unaffected first-degree relatives and first-episode and chronic schizophrenia.

Authors:  Elena Magno; Sherlyn Yeap; Jogin H Thakore; Hugh Garavan; Pierfilippo De Sanctis; John J Foxe
Journal:  Biol Psychiatry       Date:  2008-05-09       Impact factor: 13.382

4.  Progress in the Prospective Study of the Schizophrenia Prodrome.

Authors:  Emery J Fu; Kristin S Cadenhead
Journal:  Curr Psychos Ther Rep       Date:  2005-12-01

5.  Automatic sensory information processing abnormalities across the illness course of schizophrenia.

Authors:  C Jahshan; K S Cadenhead; A J Rissling; K Kirihara; D L Braff; G A Light
Journal:  Psychol Med       Date:  2011-07-11       Impact factor: 7.723

6.  Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses.

Authors:  Veronica B Perez; Neal R Swerdlow; David L Braff; Risto Näätänen; Gregory A Light
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

Review 7.  Electrophysiological Endophenotypes for Schizophrenia.

Authors:  Emily M Owens; Peter Bachman; David C Glahn; Carrie E Bearden
Journal:  Harv Rev Psychiatry       Date:  2016 Mar-Apr       Impact factor: 3.732

8.  Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing.

Authors:  Rajendra A Morey; Seniha Inan; Teresa V Mitchell; Diana O Perkins; Jeffrey A Lieberman; Aysenil Belger
Journal:  Arch Gen Psychiatry       Date:  2005-03

9.  Demand and modality of directed attention modulate "pre-attentive" sensory processes in schizophrenia patients and nonpsychiatric controls.

Authors:  Anthony J Rissling; Sung-Hyouk Park; Jared W Young; Michelle B Rissling; Catherine A Sugar; Joyce Sprock; Daniel J Mathias; Marlena Pela; Richard F Sharp; David L Braff; Gregory A Light
Journal:  Schizophr Res       Date:  2013-03-11       Impact factor: 4.939

10.  Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.

Authors:  Karsten Heekeren; Jörg Daumann; Anna Neukirch; Carsten Stock; Wolfram Kawohl; Christine Norra; Till D Waberski; Euphrosyne Gouzoulis-Mayfrank
Journal:  Psychopharmacology (Berl)       Date:  2008-05-18       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.